CDC6 plays a critical role in regulation of the onset of DNA replication in eukaryotic cells. We have found thatCdc6 expression is down-regulated in prostate cancer as detected by semiquantitative reverse transcriptase-PCR of prostate cell lines and laser-captured microdissected prostate tissues. This result was substantiated by immunohistochemical analysis of paraffin-embedded tissue sections and immunoblot analysis of benign (BPH-1) and adenocarcinomatous prostatic cells. Furthermore, a 100-fold reduction in the transcription efficiency of the Cdc6promoter-luciferase construct was noted in the metastatic PC3 cells compared with that in BPH-1 cells. Concentration of the E2F and Oct1 transcription factors that have putative binding sites in theCdc6 promoter was substantially low in PC3 cells compared with BPH cells. Mutagenesis of the two E2F binding sites on theCdc6 promoter resulted in increased promoter activity in PC3 cells owing to elimination of the negative regulation by pRb·E2F complex but not to the level of that obtained in BPH cells. We conclude that an altered interaction of transcription factors may be responsible for the down-regulation of Cdc6transcription in PC3 cells. Our study suggests a potential use of the lack of CDC6 expression as an index of prostate cancer development.
Down-regulation of Cdc6, a Cell Cycle Regulatory Gene, in Prostate Cancer*
L. Robles,A. Frost,Mónica Dávila,A. Hutson,W. Grizzle,R. Chakrabarti
Published 2002 in Journal of Biological Chemistry
ABSTRACT
PUBLICATION RECORD
- Publication year
2002
- Venue
Journal of Biological Chemistry
- Publication date
2002-07-12
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-47 of 47 references · Page 1 of 1
CITED BY
Showing 1-46 of 46 citing papers · Page 1 of 1